NICE guideline NG28 recommends SGLT2 inhibitors as an option for adults with type 2 diabetes, particularly those with established cardiovascular disease or chronic kidney disease
It is worth noting that there is no official link between injection timing (morning versus evening) and appetite control, though some patients report subjective preferences
The FDA prescribing information explicitly states that semaglutide must not be frozen
Retatrutide is an investigational drug that is not approved by the FDA or any regulatory body for the treatment of obesity, diabetes, or body recomposition outside of clinical trials
Is Insurance Required for GLP-1 Medication
In general, fatigue is reported to be less common in patients taking Ozempic compared to those taking Wegovy, likely because Ozempic uses a lower dose of semaglutide and produces less aggressive weight loss